Farallon Capital Management »

Synopsys shares owned by Farallon Capital Management

Quarter-by-quarter ownership of Synopsys (SNPS) shares owned by Farallon Capital Management from 13F filings

Historical chart of Farallon Capital Management investment in Synopsys

Tip: Access up to 7 years of quarterly data

All positions including Synopsys held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Synopsys by Farallon Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $469M 999k 469.72

More positions owned by Farallon Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Revolution Medicines (RVMD)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Aon Shs Cl A (AON)
Natera (NTRA)
Boston Scientific Corporation (BSX)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP)
Exelixis (EXEL)
Bridgebio Pharma (BBIO)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Protagonist Therapeutics (PTGX)
Wabtec Corporation (WAB)
UnitedHealth (UNH)
Cyberark Software SHS (CYBR)

View all positions for Farallon Capital Management

Top funds holding Synopsys

Vanguard Group
BlackRock
State Street Corporation
Capital World Investors
FMR
Nvidia Corp
Geode Capital Management
Victory Capital Management
Edgewood Management
Van Eck Associates Corp.
Susquehanna International
Aspex Management
Wellington Management Company
Jpmorgan Chase & Co
Ubs Global Asset Management Americas

View all funds holding Synopsys